Oxford Nanopore Technologies has听raised 拢195 million.听
The firm, spun out of Professor Hagan Bayley鈥檚 University of Oxford lab, has developed a real-time DNA/RNA sequencer and can assist with accurate, rapid testing in cancer and infectious disease.听听
Oxford Nanopore’s sequencing devices are being used in scientific research worldwide, and increasingly in regulated environments such as healthcare and food safety.听听听
The technology is being used for epidemiology and research purposes in the听COVID-19 pandemic, helping to track听mutations of听coronavirus听as they spring up around the world.听It has also听developed a听diagnostic test to identify the presence of the virus which causes COVID.听
In March,听the company revealed plans to float on the London Stock Exchange听later this year while appointing a CFO and General Counsel.听
New investors Temasek, Wellington Management, M&G Investments and Nikon听have invested 拢125m,听with existing shareholders investing 拢70m.听